Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 3, 2009, Pages 792-800

  Reimers, Laura L ^a   Anderson, William F ^a,b   Rosenberg, Philip S ^b   Henson, Donald E ^a   Castle, Philip E ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER TISSUE; CROSS-SECTIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS; AGE; AGED; CANCER REGISTRY; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; INCIDENCE; MIDDLE AGED; REGISTER; RISK FACTOR; TIME; UNITED STATES; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 64549139388     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0965     Document Type: Article

References (52)

1. Altekruse SF, Lacey JV, Jr., Brinton LA, et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 2003;188:657-663 (Pubitemid 36332430)
2. Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening andpre vention. J Natl Cancer Inst 2006;98:303-315 (Pubitemid 43338210)
3. Burk RD, Terai M, Gravitt PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003;63:7215-7220 (Pubitemid 37413460)
4. Lacey JV, Jr., Swanson CA, Brinton LA, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003;98:814-821 (Pubitemid 36959279)
5. Berrington de Gonzalez A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004;90:1787-1791 (Pubitemid 38725654)
6. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol 2000;78:97-105. (Pubitemid 30650338)
7. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003;102:765-773 (Pubitemid 37206413)
8. Zheng T, Holford TR, Ma Z, et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 1996;25:252-258 (Pubitemid 26137104)
9. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045-1047 (Pubitemid 17207273)
10. Beral V, Hermon C, Munoz N, Devesa SS. Cervical cancer. Cancer Survf 1994;19-20:265-285 (Pubitemid 24289389)
11. Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486-498
12. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
13. Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76:1948-1955
14. Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007;7:164. (Pubitemid 47506056)
15. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39:311-324
16. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda (MD): National Cancer Institute; 2007.
17. Fritz AY, Percy C, Jack A, Parkin MD. International Classification of Diseases for Oncology (ICD-O). Third Edition (International Classification of Diseases for Oncology): World Health Organization; 2000.
18. Wang SS, Sherman ME, Hildesheim A, Lacey JV, Jr., Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044
19. Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and a denocarcinoma in the United States. Relation to incidence and survival. Cancer 2005;103:1258-1264
20. Oehlert GW. A note on the D method. Am Stat 1992;46:27-29
21. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-304
22. Anderson WF, Matsuno RK, Sherman ME, et al. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 2007;18:439-447 (Pubitemid 46434789)
23. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987;6:449-467
24. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991;12:425-457
25. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987;6:469-481
26. Tarone RE, Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996;143:85-91. (Pubitemid 26011659)
27. Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM. Age-related crossover in breast cancer incidence rates between Black and White Ethnic Groups. J Natl Cancer Inst 2008;100:1804-1814
28. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 2003;63:4862-4871 (Pubitemid 37022618)
29. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 2004;91:1983-1989
30. Davey DD, Cox JT, Austin RM, et al. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis 2008;12:71-81.
31. Wang PD, Lin RS. Age-period-cohort analysis of cervical cancer mortality in Taiwan, 1974-1992. Acta Obstet Gynecol Scand 1997;76:697-702.
32. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-686 (Pubitemid 40489214)
33. Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-2199 (Pubitemid 41603267)
34. Merrill RM. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, andovarian cancers in the United States. Ann Epidemiol 2006;16:880-887 (Pubitemid 44855648)
35. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med2003; 348:518-527 (Pubitemid 36159887)
36. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-632 (Pubitemid 46986496)
37. Dong SM, Kim HS, Rha SH, Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001;7:1982-1986 (Pubitemid 32994835)
38. Wisman GB, Nijhuis ER, Hoque MO, et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006;119:1908-1914 (Pubitemid 44356850)
39. Jeong DH, Youm MY, Kim YN, et al. Promoter methylation of p16, DAPK, CDH1, and TIM P-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer 2006;16:1234-1240 (Pubitemid 43886751)
40. Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res 2003;9:2981-2984 (Pubitemid 36993256)
41. Contag SA, Gostout BS, Clayton AC, Dixon MH, McGovern RM, Calhoun ES. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;95:610-617 (Pubitemid 39592529)
42. Chao A, Wang TH, Lee YS, et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006;119:91-98
43. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus infected women. J Natl Cancer Inst 2002;94:1406-1414 (Pubitemid 35154145)
44. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14:1165-1170 (Pubitemid 40656462)
45. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003;14:805-814 (Pubitemid 37500732)
46. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-28
47. Lacey JV, Jr., Frisch M, Brinton LA, et al. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 2001;12:153-161 (Pubitemid 32165273)
48. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-891 (Pubitemid 46175411)
49. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-439 (Pubitemid 38998826)
50. Madeleine MM, Anttila T, Schwartz SM, et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007;120:650-655 (Pubitemid 44969037)
51. Lacey JV, Jr., Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999;8:1079-1085 (Pubitemid 30004905)
52. Lacey JV, Jr., Brinton LA, Barnes WA, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000;77:149-154 (Pubitemid 30217318)